1. ‘Statistical Considerations in the Design of Clinical Trials’. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1998.
2. Food and Drug Administration. ‘Guideline for the format and content of the clinical and statistical sections of an application’, FDA, US Department of Health and Human Services, Rockville, MA, U.S.A. 1988.
3. Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP working party on efficacy of medicinal products note for guidance III/3630/92-EN
4. Observational Studies, Springer-Verlag, New York, 1995.
5. The Design of Experiments, Hafner, New York.